A detailed history of Legacy Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 9,136 shares of ABBV stock, worth $1.55 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
9,136
Previous 8,736 4.58%
Holding current value
$1.55 Million
Previous $1.5 Million 20.43%
% of portfolio
0.35%
Previous 0.3%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $65,536 - $79,732
400 Added 4.58%
9,136 $1.8 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $13,002 - $15,183
-84 Reduced 0.95%
8,736 $1.5 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $64,087 - $73,022
401 Added 4.76%
8,820 $1.61 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $69,488 - $78,259
505 Added 6.38%
8,419 $1.3 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $211,205 - $244,501
1,581 Added 24.96%
7,914 $1.18 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $228,447 - $284,287
-1,724 Reduced 21.4%
6,333 $853,000
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $119,592 - $137,728
827 Added 11.44%
8,057 $1.28 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $229,594 - $275,344
1,660 Added 29.8%
7,230 $1.17 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $99,986 - $114,677
745 Added 15.44%
5,570 $748,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $73,764 - $93,778
-536 Reduced 10.0%
4,825 $739,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $181,340 - $224,992
1,374 Added 34.46%
5,361 $869,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $22,882 - $28,953
213 Added 5.64%
3,987 $540,000
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $35,218 - $39,978
-331 Reduced 8.06%
3,774 $407,000
Q2 2021

Jul 21, 2021

SELL
$105.21 - $117.21 $68,807 - $76,655
-654 Reduced 13.74%
4,105 $462,000
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $16,163 - $17,793
158 Added 3.43%
4,759 $515,000
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $33,403 - $45,098
415 Added 9.91%
4,601 $491,000
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $359,619 - $422,074
4,186 New
4,186 $367,000
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $222,783 - $337,766
-3,454 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $3,245 - $4,061
-45 Reduced 1.29%
3,454 $306,000
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $9,447 - $11,358
-150 Reduced 4.11%
3,499 $265,000
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $919 - $1,175
14 Added 0.39%
3,649 $265,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $19,362 - $22,788
-251 Reduced 6.46%
3,635 $293,000
Q4 2018

Jan 16, 2019

SELL
$77.85 - $96.01 $7,473 - $9,216
-96 Reduced 2.41%
3,886 $358,000
Q3 2018

Oct 30, 2018

SELL
$88.91 - $98.84 $5,067 - $5,633
-57 Reduced 1.41%
3,982 $376,000
Q2 2018

Jul 17, 2018

BUY
$89.78 - $106.23 $1,795 - $2,124
20 Added 0.5%
4,039 $390,000
Q1 2018

Apr 12, 2018

BUY
$92.01 - $123.21 $6,532 - $8,747
71 Added 1.8%
4,019 $376,000
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $353,582 - $387,733
3,948
3,948 $381,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Legacy Financial Advisors, Inc. Portfolio

Follow Legacy Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.